abstract |
The present invention relates to compounds that interact with ion channels. In particular, the present invention has the following formulas I, II, III or IV, wherein X 1 , X 2 , Y, Z, W, R 1 , R 8 , R 10 , L, A, z and n are defined in claim 1 Compounds, stereoisomers, tautomers, racemates, prodrugs, metabolites, or pharmaceutically acceptable salts and / or solvates thereof. The invention also relates to methods of preparing said compounds, pharmaceutical compositions comprising said compounds, and to the use of said compounds in methods of treating human and animal bodies. |